Management of hepatitis C virus infection in the setting of liver transplantation.
about
Management of HCV infection and liver transplantation.Management of Hepatitis C Post-liver Transplantation: a Comprehensive ReviewHepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and ManagementFibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantationPegylated IFN-α and ribavirin: emerging data in the treatment of special populations.Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis.Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.General aspects and pitfalls in liver transplant pathology.Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a retrospective review.Immunosuppression, liver injury and post-transplant HCV recurrence.Hepatitis C recurrence: the Achilles heel of liver transplantation.Update on the Development of Anti-Viral Agents Against Hepatitis C.Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C.Fibrosing Cholestatic Hepatitis in a Complicated Case of an Adult Recipient After Liver Transplantation: Diagnostic Findings and Therapeutic Dilemma.Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation.Antiviral re-treatment of IFN-ribavirin non-responders for recurrent post-transplantation hepatitis C.Antiviral treatment withdrawal in viremic HCV-positive liver transplant patients: impact on viral loads, allograft function and morphology.Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.Impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
P2860
Q24541563-58ECA1CE-2FC4-4AC9-9D6C-11065FD62635Q26781741-27353D8F-188C-4BCE-88F5-3275DD57B881Q26781984-D4F1766D-37E6-49A5-A8FB-577148EBE5FAQ28076406-4255F28A-1CFE-4584-AA4A-BB59B9063D8DQ30733177-61BDDEB3-D2E6-4805-85B2-75121C20C150Q34232434-9475CAE9-445E-49E0-9DC0-E19457C84B0BQ35808230-D48ADBCD-C239-47C1-9EE0-9B6D638D89E7Q36530402-9598F4AA-C897-4ED2-B950-F042770041A2Q36652053-9098287A-8E40-418B-A7EB-A9824AD64327Q37222388-27DBC06A-B1B6-42E5-B7EB-8461DD9FDF68Q37970381-974644B0-C2FE-4AE8-8641-F5A8133A9303Q38174194-A781C20A-3097-4E3A-A71C-0CB0A04F488CQ38584271-54B543FE-503F-476F-8D57-026A92C25C43Q40211269-75CDA9AC-DE82-48A4-9956-3A47FEE870AEQ40568564-ED0D862B-9E0A-4E1C-8CF0-B8F53BF5D31FQ42230188-39C4C6DB-6295-47D1-85A5-E9FA3A595888Q42996792-C369BE93-21C4-47E7-81D4-7946488F1C63Q43030608-0FA9E91E-F274-4441-88E1-DF62453FE5B7Q50575004-3B810B16-0400-4A62-B001-3B01D8909B42Q50576126-02C746FA-FB47-4C72-A33D-70F0A28F0759
P2860
Management of hepatitis C virus infection in the setting of liver transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Management of hepatitis C virus infection in the setting of liver transplantation.
@ast
Management of hepatitis C virus infection in the setting of liver transplantation.
@en
type
label
Management of hepatitis C virus infection in the setting of liver transplantation.
@ast
Management of hepatitis C virus infection in the setting of liver transplantation.
@en
prefLabel
Management of hepatitis C virus infection in the setting of liver transplantation.
@ast
Management of hepatitis C virus infection in the setting of liver transplantation.
@en
P356
P1476
Management of hepatitis C virus infection in the setting of liver transplantation
@en
P2093
Hector Rodriguez-Luna
P2860
P304
P356
10.1002/LT.20424
P577
2005-05-01T00:00:00Z